Search results | NICE

1 result

Sorted by Date . Sort by Relevance

Guidance Remove Guidance filter
Last 3 months Remove Last 3 months filter
Diagnostics guidance Remove Diagnostics guidance filter
COVID-19 NHSE/I specialty guides Remove COVID-19 NHSE/I specialty guides filter

Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) (DG47)

NICE no longer plans to develop guidance on Freelite assays for diagnosing multiple myeloma and related conditions in primary care. We will review this decision if a stakeholder notifies NICE again of the topic

Type

Diagnostics guidance

Published

30 March 2022
Show all sections for DG47
Sections for DG47

Overview

Advice